Literature DB >> 32037260

CT-Radiomic Approach to Predict G1/2 Nonfunctional Pancreatic Neuroendocrine Tumor.

Zengrui Zhao1, Yun Bian2, Hui Jiang3, Xu Fang2, Jing Li2, Kai Cao2, Chao Ma2, Li Wang2, Jianming Zheng3, Xiaodong Yue4, Huiran Zhang5, Xiangxue Wang6, Anant Madabhushi6, Jun Xu7, Gang Jin8, Jianping Lu9.   

Abstract

RATIONALE AND
OBJECTIVES: Tumor grading of nonfunctional pancreatic neuroendocrine tumors (NF-pNETs) determines the choice of clinical treatment and management. The pathological grade of pancreatic neuroendocrine tumors is usually assessed on postoperative specimens. The goal of our study is to establish a tumor grade (G) prediction model for preoperative G1/2 NF-pNETs using radiomics for multislice spiral CT image analysis.
MATERIALS AND METHODS: This retrospective study included a primary cohort of 59 patients and an independent validation cohort of 40 consecutive patients; their multislice spiral CT images were collected from October 2012 to October 2016 and October 2016 to June 2018, respectively. All 99 patients were diagnosed with clinicopathologically confirmed NF-pNETs. Most significant radiomic features were selected using the minimum redundancy and maximum relevance algorithm. Support vector machine classifier with a radial basis function-based predictive model was subsequently developed for clinical use.
RESULTS: A total of 585 radiomics features were extracted from every phase for each patient. Six of these radiomics features were identified as most discriminant features for G1 and G2 tumors and used to construct the tumor grade prediction model. The prediction model resulted in the area under the curve values of 0.968 (95% CI: 0.900-0.991) and 0.876 (95% CI: 0.700-0.963) for the training cohort and validation cohort, respectively. Sensitivity and specificity were 96.4% and 83.9%, and 90.9% and 88.9% for the training and validation cohorts, respectively. The decision curves indicated that if the threshold probability is above 0.1, using the rad-score in the current study on G1/2 NF-pNETs is more beneficial than the treat-all-patients scheme or the treat-none scheme.
CONCLUSION: Radiomics developed with a combination of nonenhanced and portal venous phases can achieve favorable predictive accuracy for histological grade for G1/G2 NF-pNETs.
Copyright © 2020 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Computer-assisted image analysis; Neoplasm grading; Neuroendocrine tumors; Pancreas neoplasms; Tomography

Year:  2020        PMID: 32037260     DOI: 10.1016/j.acra.2020.01.002

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  8 in total

1.  Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a radiomic model to predict tumor grade.

Authors:  Giuditta Chiti; Giulia Grazzini; Federica Flammia; Benedetta Matteuzzi; Paolo Tortoli; Silvia Bettarini; Elisa Pasqualini; Vincenza Granata; Simone Busoni; Luca Messserini; Silvia Pradella; Daniela Massi; Vittorio Miele
Journal:  Radiol Med       Date:  2022-08-02       Impact factor: 6.313

Review 2.  GEP-NET radiomics: a systematic review and radiomics quality score assessment.

Authors:  Femke C R Staal; Else A Aalbersberg; Daphne van der Velden; Erica A Wilthagen; Margot E T Tesselaar; Regina G H Beets-Tan; Monique Maas
Journal:  Eur Radiol       Date:  2022-07-26       Impact factor: 7.034

Review 3.  Update on quantitative radiomics of pancreatic tumors.

Authors:  Mayur Virarkar; Vincenzo K Wong; Ajaykumar C Morani; Eric P Tamm; Priya Bhosale
Journal:  Abdom Radiol (NY)       Date:  2021-07-22

Review 4.  Machine intelligence in non-invasive endocrine cancer diagnostics.

Authors:  Nicole M Thomasian; Ihab R Kamel; Harrison X Bai
Journal:  Nat Rev Endocrinol       Date:  2021-11-09       Impact factor: 43.330

Review 5.  The impact of radiomics in diagnosis and staging of pancreatic cancer.

Authors:  Calogero Casà; Antonio Piras; Andrea D'Aviero; Francesco Preziosi; Silvia Mariani; Davide Cusumano; Angela Romano; Ivo Boskoski; Jacopo Lenkowicz; Nicola Dinapoli; Francesco Cellini; Maria Antonietta Gambacorta; Vincenzo Valentini; Gian Carlo Mattiucci; Luca Boldrini
Journal:  Ther Adv Gastrointest Endosc       Date:  2022-03-16

Review 6.  Using Quantitative Imaging for Personalized Medicine in Pancreatic Cancer: A Review of Radiomics and Deep Learning Applications.

Authors:  Kiersten Preuss; Nate Thach; Xiaoying Liang; Michael Baine; Justin Chen; Chi Zhang; Huijing Du; Hongfeng Yu; Chi Lin; Michael A Hollingsworth; Dandan Zheng
Journal:  Cancers (Basel)       Date:  2022-03-24       Impact factor: 6.639

7.  Development and Validation of a Novel Radiomics-Based Nomogram With Machine Learning to Preoperatively Predict Histologic Grade in Pancreatic Neuroendocrine Tumors.

Authors:  Xing Wang; Jia-Jun Qiu; Chun-Lu Tan; Yong-Hua Chen; Qing-Quan Tan; Shu-Jie Ren; Fan Yang; Wen-Qing Yao; Dan Cao; Neng-Wen Ke; Xu-Bao Liu
Journal:  Front Oncol       Date:  2022-03-31       Impact factor: 6.244

8.  Application of CT-Based Radiomics in Discriminating Pancreatic Cystadenomas From Pancreatic Neuroendocrine Tumors Using Machine Learning Methods.

Authors:  Xuejiao Han; Jing Yang; Jingwen Luo; Pengan Chen; Zilong Zhang; Aqu Alu; Yinan Xiao; Xuelei Ma
Journal:  Front Oncol       Date:  2021-07-22       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.